Michael A. Mussallem, Director at Edwards Lifesciences Corp (EW), sold 31,850 shares at $73.46 ($2.3M) on 2024-01-05, disclosed to the SEC on 2024-01-05.
Scheduled sale ($2.3M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $72.94 | 26,850 | $2.0M | 84.2% |
| 2 | $73.46 | 2,500 | $184K | 7.9% |
| 3 | $73.46 | 2,500 | $184K | 7.9% |
| Total | $73.02 avg | 31,850 | $2.3M | 100% |
| Filing → |
| EW | SELL | 2024-03-04 | $3.7M | — | Filing → |
| EW | SELL | 2024-02-05 | $5.0M | — | Filing → |
| EW | SELL | 2023-12-13 | $3.6M | — | Filing → |